Raymond G. Schlienger

Senior Expert Epidemiologist
Novartis Pharma AG, Switzerland

Novartis Pharma AG (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Poster(s):

• (P-050) Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results

• (P-428) Incidence of Angioedema After Initiation of Angiotensin-converting Enzyme Inhibitors in Adults with Heart Failure